Britannia Life Sciences Inc.
BLAB
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.74M | 12.31M | 11.59M | 618.60K | 4.50M |
| Total Receivables | 1.09M | 821.50K | 404.10K | 214.40K | 147.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 27.30K | 34.00K | 49.30K | 9.20K | 9.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 331.20K | 329.80K | 334.90K | 1.33M | 1.32M |
| Total Current Assets | 10.19M | 13.49M | 12.37M | 2.18M | 5.98M |
|
|
|||||
| Total Current Assets | 10.19M | 13.49M | 12.37M | 2.18M | 5.98M |
| Net Property, Plant & Equipment | 45.80K | 57.00K | 69.30K | 80.60K | 93.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 0.00 | 0.00 | -- | -- |
| Total Assets | 17.48M | 17.14M | 16.09M | 7.41M | 7.19M |
|
|
|||||
| Total Accounts Payable | 714.60K | 956.80K | 2.44M | 982.70K | 1.04M |
| Total Accrued Expenses | 741.70K | 753.30K | 899.20K | 1.04M | 751.30K |
| Short-term Debt | 20.90K | 20.90K | 21.20K | 21.20K | 21.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 110.70K | 118.40K | 123.60K | 121.10K | 125.20K |
| Total Finance Division Other Current Liabilities | 201.10K | 205.20K | -- | -- | -- |
| Total Other Current Liabilities | 201.10K | 205.20K | -- | -- | -- |
| Total Current Liabilities | 1.79M | 2.05M | 3.49M | 2.17M | 1.94M |
|
|
|||||
| Total Current Liabilities | 1.79M | 2.05M | 3.49M | 2.17M | 1.94M |
| Long-Term Debt | -- | -- | -- | 1.56M | 1.12M |
| Short-term Debt | 20.90K | 20.90K | 21.20K | 21.20K | 21.70K |
| Capital Leases | 17.20K | 25.20K | 36.40K | 52.60K | 69.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 156.30K | 159.50K | -- | -- | -- |
| Total Liabilities | 1.96M | 2.24M | 3.52M | 3.78M | 3.13M |
|
|
|||||
| Common Stock & APIC | 14.57M | 14.74M | 14.96M | 14.73M | 15.04M |
| Retained Earnings | 1.78M | 960.40K | -1.65M | -10.33M | -10.25M |
| Treasury Stock & Other | -837.90K | -793.60K | -746.00K | -771.10K | -725.90K |
| Total Common Equity | 15.52M | 14.90M | 12.57M | 3.63M | 4.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.52M | 14.90M | 12.57M | 3.63M | 4.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.52M | 14.90M | 12.57M | 3.63M | 4.07M |
|
|
|||||